Literature DB >> 14586458

Virology: SARS virus infection of cats and ferrets.

Byron E E Martina1, Bart L Haagmans, Thijs Kuiken, Ron A M Fouchier, Guus F Rimmelzwaan, Geert Van Amerongen, J S Malik Peiris, Wilina Lim, Albert D M E Osterhaus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586458      PMCID: PMC7094990          DOI: 10.1038/425915a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.

Main

Serological and virological studies have indicated that Chinese ferret badgers (Melogale moschata), masked palm civets (Paguma larvata) and raccoon dogs (Nyctereutes procyonoides) can be infected with a virus that is very similar to SCV (ref. 3). Domestic cats living in the Amoy Gardens apartment block in Hong Kong, where more than 100 residents contracted SARS last year, were also found to be infected with SCV. To test the susceptibility of domestic cats and ferrets to SCV infection, we inoculated them intratracheally with 106 median tissue-culture infectious dose units (TCID50), which we obtained from patient 5688 (who died from SARS) and then passaged four times on Vero 118 cells[4,5] in vitro. We then took nasal, pharyngeal and rectal swabs from the animals on different days post-infection (p.i.). Four animals from each group were killed at 4 days p.i. and were necropsied according to a standard protocol[4,5]. No clinical signs were seen in SCV-inoculated cats, whereas three out of six ferrets became lethargic from days 2–4 p.i. and one of these ferrets died 4 days p.i. All cats (Fig. 1a) and ferrets (Fig. 1b) shed SCV from the pharynx, starting at 2 days p.i. and continuing until days 10 and 14, respectively, as demonstrated by polymerase chain reaction with reverse transcription (RT-PCR)[5]. The virus was isolated[4,5] from all pharyngeal swabs taken on days 2–8 p.i. and from nasal swabs taken from two cats on days 4 and 6 p.i. SCV was not detected in nasal swabs from ferrets or in rectal swabs from cats or ferrets.
Figure 1

Daily excretion of SARS coronavirus (SCV) in ferrets and domestic cats after inoculation with the virus or exposure to infected animals.

a, b, SCV titres per ml from cats (a) and ferrets (b) (n = 6 of each) that had been inoculated with SCV through the respiratory route. Four animals from each group were killed on the fourth day after infection, and two were kept until day 28. c, d, SCV titres from non-inoculated cats (c) and ferrets (d) (n = 2 of each) that had been housed with inoculated cats and ferrets, respectively. SCV excretion was quantified in pharyngeal swabs by using reverse transcription with the polymerase chain reaction, and was compared to a titrated SCV standard. ND, not determined.

Daily excretion of SARS coronavirus (SCV) in ferrets and domestic cats after inoculation with the virus or exposure to infected animals.

a, b, SCV titres per ml from cats (a) and ferrets (b) (n = 6 of each) that had been inoculated with SCV through the respiratory route. Four animals from each group were killed on the fourth day after infection, and two were kept until day 28. c, d, SCV titres from non-inoculated cats (c) and ferrets (d) (n = 2 of each) that had been housed with inoculated cats and ferrets, respectively. SCV excretion was quantified in pharyngeal swabs by using reverse transcription with the polymerase chain reaction, and was compared to a titrated SCV standard. ND, not determined. Infection of the respiratory tract was evident in all animals tested: SCV was isolated from the trachea and lungs (see supplementary information). Quantification of the viral titres in lung homogenates revealed relatively low SCV titres (geometric mean ± s.d.) in the lungs of SCV-inoculated cats (1 × 103 ± 0.51 TCID50 ml−1) compared with those in ferrets (1 × 106 ± 0.70 TCID50 ml−1). Histologically, SCV infection was associated with pulmonary lesions similar to those seen in SCV-infected macaques[4,5], except that they were milder, particularly in SCV-infected cats, and did not feature syncytia. In the gastrointestinal and urinary tracts, SCV was detected by RT-PCR (see supplementary information). Follow-up of the remaining SCV-inoculated animals (n = 2 per group) revealed that they had all seroconverted[5] by 28 days p.i. (neutralizing antibody titres of 40–320). Two attempts to infect suckling mice through intracerebral inoculation failed. Non-inoculated cats (Fig. 1c; n = 2) and ferrets (Fig. 1d; n = 2) that were housed with the inoculated cats and ferrets, respectively, became infected with SCV: viral titres gradually increased from 2 days p.i. onwards, peaking at days 6–8 p.i. Neither of the cats showed clinical signs of infection, but both had seroconverted by day 28 (they had virus-neutralizing antibody titres of 40 and 160, respectively). Both ferrets were lethargic and developed conjunctivitis; they died on days 16 and 21 p.i. We established by pathological examination that the main lesions in both animals were marked hepatic lipidosis and emaciation. There was no evidence that either of these animals died from SCV-associated pneumonia, although SCV was isolated from post-mortem lung specimens of one animal. Our results show that ferrets and domestic cats are susceptible to experimental infection by SCV, and that the virus is efficiently transmitted to animals living with them. These species might therefore be useful as animal models to test antiviral drugs or vaccine candidates against SARS. Supplementary Table (DOC 30 kb)
  5 in total

1.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.

Authors:  Y Guan; B J Zheng; Y Q He; X L Liu; Z X Zhuang; C L Cheung; S W Luo; P H Li; L J Zhang; Y J Guan; K M Butt; K L Wong; K W Chan; W Lim; K F Shortridge; K Y Yuen; J S M Peiris; L L M Poon
Journal:  Science       Date:  2003-09-04       Impact factor: 47.728

3.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

4.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

Authors:  Thijs Kuiken; Ron A M Fouchier; Martin Schutten; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Jon D Laman; Ton de Jong; Gerard van Doornum; Wilina Lim; Ai Ee Ling; Paul K S Chan; John S Tam; Maria C Zambon; Robin Gopal; Christian Drosten; Sylvie van der Werf; Nicolas Escriou; Jean-Claude Manuguerra; Klaus Stöhr; J S Malik Peiris; Albert D M E Osterhaus
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

5.  Aetiology: Koch's postulates fulfilled for SARS virus.

Authors:  Ron A M Fouchier; Thijs Kuiken; Martin Schutten; Geert van Amerongen; Gerard J J van Doornum; Bernadette G van den Hoogen; Malik Peiris; Wilina Lim; Klaus Stöhr; Albert D M E Osterhaus
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

  5 in total
  298 in total

1.  Why SARS will not return: a polemic.

Authors:  Donald E Low
Journal:  CMAJ       Date:  2004-01-06       Impact factor: 8.262

2.  Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis.

Authors:  Z F Sun; X J Meng
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 3.  Severe acute respiratory syndrome (SARS): epidemiology and clinical features.

Authors:  D S C Hui; M C H Chan; A K Wu; P C Ng
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

Review 4.  Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.

Authors:  Wenhui Li; Swee-Kee Wong; Fang Li; Jens H Kuhn; I-Chueh Huang; Hyeryun Choe; Michael Farzan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques.

Authors:  Li Liu; Qiang Wei; Xavier Alvarez; Haibo Wang; Yanhua Du; Hua Zhu; Hong Jiang; Jingying Zhou; Pokman Lam; Linqi Zhang; Andrew Lackner; Chuan Qin; Zhiwei Chen
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

6.  Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.

Authors:  Yi Wang; Ying Sun; Andong Wu; Shan Xu; Ruangang Pan; Cong Zeng; Xu Jin; Xingyi Ge; Zhengli Shi; Tero Ahola; Yu Chen; Deyin Guo
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

7.  Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.

Authors:  Dong P Han; Motashim Lohani; Michael W Cho
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  Reservoir interactions and disease emergence.

Authors:  T Reluga; R Meza; D B Walton; A P Galvani
Journal:  Theor Popul Biol       Date:  2007-07-25       Impact factor: 1.570

9.  The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.

Authors:  Scott R Schaecher; Jason M Mackenzie; Andrew Pekosz
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.

Authors:  Laura Gillim-Ross; Jill Taylor; David R Scholl; Jared Ridenour; Paul S Masters; David E Wentworth
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.